These two authors have contributed equally to this work.
Letter to the Editor
You have free access to this content
Bioactive tetrapeptide GEKG boosts extracellular matrix formation: in vitro and in vivo molecular and clinical proof
Article first published online: 22 JUN 2011
DOI: 10.1111/j.1600-0625.2011.01307.x
© 2011 John Wiley & Sons A/S
Additional Information
How to Cite
Farwick, M., Grether-Beck, S., Marini, A., Maczkiewitz, U., Lange, J., Köhler, T., Lersch, P., Falla, T., Felsner, I., Brenden, H., Jaenicke, T., Franke, S. and Krutmann, J. (2011), Bioactive tetrapeptide GEKG boosts extracellular matrix formation: in vitro and in vivo molecular and clinical proof. Experimental Dermatology, 20: 602–604. doi: 10.1111/j.1600-0625.2011.01307.x
- †
These two authors have contributed equally to this work.
Publication History
- Issue published online: 22 JUN 2011
- Article first published online: 22 JUN 2011
- Accepted for publication 15 April 2011
References
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8, , , , , . Int J Cosmet Sci 2005: 27: 155–160.Direct Link:
- 9, , et al. J Am Acad Dermatol 2005: 52: Abstract 96.
- 10, , et al. Int J Cosmet Sci 2002: 24: 303–310.Direct Link:
- 11, , , inventors. Peptide fragments for inducing synthesis of extracellular matrix proteins. PCT/WO 2007/146269 A2.
- 12, , inventors. Personal care and cosmetic composition containing tetrapeptides with motifs GX1X2G, PX1X2P, or PX1X2K. PCT/WO 2009/068351 A2.
- 13, , et al. Exp Dermatol 2008: 17: 771–779.
- 14, , et al. Exp Dermatol 2010: 19: e182–e190.
- 15, . Exp Dermatol 2010: 19: 878–882.
- 16
- 17, , et al. Arch Dermatol Res 2000: 292: 500–510.
- 18, , et al. Skin Res Technol 2004: 10: 207–214.
- 19, , et al. In: New Developments in Biomedical Engineering. (ed.). INTECH, Rijeka, 2010: 341–358.
- 20, . In: Advanced Techniques for Assessment Surface Topography. Development of a Basis for 3D Surface Texture Standards “Surfstand”. , (eds). London: Kogan Page Limited, 2003: 17–42.

1600-0625/asset/bannerforeground.gif?v=1&s=286b1e3eed08e680174fd346cc9fdf2ece9544a4)
